UniSa - IRIS Institutional Research Information System

MAROTTA, Vincenzo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 5.466
SA - Sud America 898
NA - Nord America 388
EU - Europa 126
AF - Africa 43
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.925
Salva come PNG Salva come JPEG
Nazione #
HK - Hong Kong 4.463
BR - Brasile 693
VN - Vietnam 395
SG - Singapore 371
US - Stati Uniti d'America 348
CN - Cina 104
AR - Argentina 81
ID - Indonesia 45
EC - Ecuador 34
PY - Paraguay 30
CO - Colombia 24
MX - Messico 24
IT - Italia 23
BD - Bangladesh 20
IN - India 19
UA - Ucraina 17
DE - Germania 14
KR - Corea 14
CL - Cile 13
RU - Federazione Russa 12
GB - Regno Unito 11
PL - Polonia 11
IQ - Iraq 10
ZA - Sudafrica 10
UY - Uruguay 9
EG - Egitto 7
MA - Marocco 7
KE - Kenya 6
PE - Perù 6
TR - Turchia 6
VE - Venezuela 6
DO - Repubblica Dominicana 5
FR - Francia 4
LT - Lituania 4
RS - Serbia 4
AL - Albania 3
AT - Austria 3
CA - Canada 3
DZ - Algeria 3
GT - Guatemala 3
IE - Irlanda 3
IL - Israele 3
NL - Olanda 3
SE - Svezia 3
UZ - Uzbekistan 3
AU - Australia 2
AZ - Azerbaigian 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
ES - Italia 2
FI - Finlandia 2
PK - Pakistan 2
RO - Romania 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
BW - Botswana 1
GE - Georgia 1
HU - Ungheria 1
IR - Iran 1
JP - Giappone 1
KW - Kuwait 1
LV - Lettonia 1
MK - Macedonia 1
ML - Mali 1
MU - Mauritius 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TG - Togo 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.925
Salva come PNG Salva come JPEG
Città #
Hong Kong 4.461
Ho Chi Minh City 153
Dallas 144
Singapore 119
Hanoi 88
São Paulo 59
Ashburn 52
Rio de Janeiro 28
Haiphong 22
Curitiba 17
Beijing 16
Boardman 16
Da Nang 16
Asunción 15
Thái Bình 14
Porto Alegre 13
Seoul 13
New York 12
Brasília 11
Los Angeles 11
Ribeirão Preto 11
Guayaquil 10
Quito 10
Salvador 10
Woodbridge 10
Biên Hòa 9
Mexico City 9
Ninh Bình 9
Ann Arbor 8
Guarulhos 8
Phủ Lý 8
Santo André 8
Buenos Aires 7
Campinas 7
Hortolândia 7
Manaus 7
Montevideo 7
Munich 7
Santiago 7
Belo Horizonte 6
Bắc Giang 6
Caxias do Sul 6
Chandler 6
Jacksonville 6
Maceió 6
Naples 6
Piracicaba 6
Recife 6
Volta Redonda 6
Warsaw 6
Baghdad 5
Bắc Ninh 5
Canoas 5
Coimbatore 5
Cuiabá 5
Hải Dương 5
Jakarta 5
Johannesburg 5
Kyiv 5
Nairobi 5
San Juan 5
Santiago de Cali 5
Sumaré 5
Araçatuba 4
Bauru 4
Cairo 4
Feira de Santana 4
Fisciano 4
Florianópolis 4
Gdansk 4
Ha Long 4
Houston 4
Huế 4
Izmir 4
Joinville 4
Juiz de Fora 4
Limeira 4
Marília 4
Medellín 4
Nha Trang 4
Nuremberg 4
Poplar 4
Sobral 4
São Bernardo do Campo 4
São João da Boa Vista 4
Aparecida de Goiânia 3
Barbacena 3
Betim 3
Bogotá 3
Buffalo 3
Campina Grande 3
Campo Grande 3
Campos dos Goytacazes 3
Catalão 3
Centenario 3
Chennai 3
Chicago 3
Contagem 3
Duque de Caxias 3
Formosa 3
Totale 5.703
Salva come PNG Salva come JPEG
Nome #
Hashimoto's thyroiditis predicts outcome in intrathyroidal papillary thyroid cancer 704
A Prospective Multicenter Study Examining the Relationship Between Thyroid Cancer Treatment Outcomes and the Presence of Autoimmune Thyroiditis 465
The primary occurrence of BRAF(V600E) is a rare clonal event in papillary thyroid carcinoma. 365
The combined use of biological investigations, bio chromatographic and in silico methods to solve the puzzle of badge and its derivative's toxicity 311
Exposure to Bisphenol A increases malignancy risk of thyroid nodules in overweight/obese patients 306
Significance of RAS Mutations in Thyroid Benign Nodules and Non-Medullary Thyroid Cancer 300
Evolution of benign thyroid nodules under levothyroxine non-suppressive therapy 295
Thyroid nodules treated with percutaneous radiofrequency thermal ablation: A comparative study 259
BRAF mutation positive papillary thyroid carcinoma is less advanced when Hashimoto's thyroiditis lymphocytic infiltration is present 245
Human exposure to bisphenol AF and diethylhexylphthalate increases susceptibility to develop differentiated thyroid cancer in patients with thyroid nodules 223
Complete disappearance of liver metastases in a patient with iodine-refractory differentiated thyroid cancer subjected to sorafenib re-challenge 190
BRAF V600E associates with cytoplasmatic localization of p27kip1 and higher cytokeratin 19 expression in papillary thyroid carcinoma 175
GH provocative tests stimulate the growth in children with idiopathic short stature 154
Great veins invasion in follicular thyroid cancer: single-centre study assessing prevalence and clinical outcome 144
Kinase-inhibitors for iodine-refractory differentiated thyroid cancer: still far from a structured therapeutic algorithm 120
Survival Predictors of Radioiodine-refractory Differentiated Thyroid Cancer Treated With Lenvatinib in Real Life 114
Fibrous Variant of Hashimoto’s Thyroiditis as a Diagnostic Pitfall in Thyroid Pathology 107
Impact of long-acting octreotide in patients with early-stage MEN1-related duodeno-pancreatic neuroendocrine tumours 105
TSH modulation in advanced differentiated thyroid cancer: a continuous walk on the tightrope between prognostic stratification, adverse events, and levothyroxine bioavailability 104
Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1 97
Papillary thyroid carcinoma with high percentage of BRAFV600E alleles have a higher recurrence rate 86
Cabozantinib in the Treatment of Neuroendocrine Neoplasms: Insights across Different Tumor Origins 84
Targeted therapy with kinase inhibitors in aggressive endocrine tumors 79
Benign thyroid nodules with RAS mutation grow faster 74
Fathoming the link between anthropogenic chemical contamination and thyroid cancer 74
Assessment and clinical implications of RANK/RANKL/OPG pathway as markers of bone tumor progression in patients with NET harboring bone metastases 73
Inibitori multichinasici nel trattamento del carcinoma differenziato tiroideo iodio-refrattario 71
Preliminary data of VEGF-A and VEGFR-2 polymorphisms as predictive factors of radiological response and clinical outcome in iodine-refractory differentiated thyroid cancer treated with sorafenib 71
A High Percentage of BRAFV600E Alleles in Papillary Thyroid Carcinoma Predicts a Poorer Outcome 65
Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors 65
Cell-Free DNA Analysis within the Challenges of Thyroid Cancer Management 64
Erratum to: Preliminary data of VEGF-A and VEGFR-2 polymorphisms as predictive factors of radiological response and clinical outcome in iodine-refractory differentiated thyroid cancer treated with sorafenib (Endocrine, (2017), 57, 3, (539-543), 10.1007/s12020-016-1200-6) 62
Editorial: Papillary thyroid cancer: prognostic factors and risk assessment 62
Are RET/PTC Rearrangements in Benign Thyroid Nodules of Biological Significance? 60
Impact of Dietary Supplements on Clinical Outcomes and Quality of Life in Patients with Breast Cancer: A Systematic Review 50
Application of molecular biology of differentiated thyroid cancer for clinical prognostication 50
Role of nutritional therapy on dietary habits and glycemic control in insulin-treated kidney transplant patients with diabetes 50
Detection of RET/PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings. 48
Chromogranin a as circulating marker for diagnosis and management of neuroendocrine neoplasms: More flaws than fame 48
RET/PTC rearrangement in benign and malignant thyroid diseases: a clinical standpoint 47
Sorafenib in advanced iodine-refractory differentiated thyroid cancer: efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PET. 47
BRAF mutation in cytology samples as a diagnostic tool for papillary thyroid carcinoma 46
Radioiodide induces apoptosis in human thyroid tissue in culture 45
Combined biological therapy with lanreotide autogel and cabergoline in the treatment of MEN-1-related insulinomas 45
Supplements in Oncology: Uses, Hurdles, Guidance, and Future Perspectives 45
Integrin–fibronectin interaction is a pivotal biological and clinical determinant in papillary thyroid carcinoma 45
Integrin–fibronectin interaction is a pivotal biological and clinical determinant in papillary thyroid carcinoma 44
BRAF V600E assessment by pyrosequencing in fine needle aspirates of thyroid nodules with concurrent Hashimoto’s thyroiditis is a reliable assay 43
Inhibition of Metalloproteinases-2, -9, and -14 Suppresses Papillary Thyroid Carcinoma Cell Migration and Invasion 42
Impact of cinacalcet hydrochloride in clinical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1 41
Interferon-γ inhibits integrin-mediated extracellular signal-regulated kinase activation stimulated by fibronectin binding in thyroid cells 41
Unintentional recurrent laryngeal nerve injuries following thyroidectomy: Is it the surgeon who pays the bill? 40
Total Thyroidectomy with Harmonic Scalpel Combined with Gelatin Thrombin Hemostatic: A Focus on the Elderly Population—A Multicentric Study 39
Potential role of cinacalcet hydrochloride in sporadic primary hyperparathyroidism without surgery indication 38
Growing thyroid nodules with benign histology and RET rearrangement 38
The evolving field of kinase inhibitors in thyroid cancer 36
Prevalence of RET/PTC rearrangement in benign and malignant thyroid nodules and its clinical application 36
Second-line sunitinib as a feasible approach for iodine-refractory differentiated thyroid cancer after the failure of first-line sorafenib 36
Interferon-γ inhibits integrin-mediated adhesion to fibronectin and survival signaling in thyroid cells 34
Germline polymorphisms of the VEGF pathway predict recurrence in nonadvanced differentiated thyroid cancer 33
Limitations of Chromogranin A in clinical practice 32
Hepatic arterial embolization in patients with neuroendocrine tumors 29
High Growth Rate of Benign Thyroid Nodules Bearing RET/PTC Rearrangements 29
First-line lenvatinib and sorafenib in RR-DTC from a shared real-life context 12
La diagnostica molecolare del nodulo tiroideo 12
Totale 6.994
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.729
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.729
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 1 0 1 0 1 0
2021/20227 0 0 1 0 0 0 0 0 1 1 1 3
2022/202312 1 0 0 1 2 4 0 0 4 0 0 0
2023/20246 2 0 0 0 0 1 0 0 0 1 0 2
2024/20258 0 0 0 2 1 1 1 1 1 0 0 1
2025/20266.921 586 2.769 2.215 1.004 335 12 0 0 0 0 0 0
Totale 6.994